TW205507B - - Google Patents

Download PDF

Info

Publication number
TW205507B
TW205507B TW081101708A TW81101708A TW205507B TW 205507 B TW205507 B TW 205507B TW 081101708 A TW081101708 A TW 081101708A TW 81101708 A TW81101708 A TW 81101708A TW 205507 B TW205507 B TW 205507B
Authority
TW
Taiwan
Prior art keywords
formula
compound
ministry
item
printed
Prior art date
Application number
TW081101708A
Other languages
English (en)
Chinese (zh)
Original Assignee
Hoechst Roussel Pharma
Hutchinson Fred Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma, Hutchinson Fred Cancer Res filed Critical Hoechst Roussel Pharma
Application granted granted Critical
Publication of TW205507B publication Critical patent/TW205507B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW081101708A 1990-11-30 1992-03-06 TW205507B (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62048090A 1990-11-30 1990-11-30

Publications (1)

Publication Number Publication Date
TW205507B true TW205507B (enExample) 1993-05-11

Family

ID=24486121

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081101708A TW205507B (enExample) 1990-11-30 1992-03-06

Country Status (10)

Country Link
EP (1) EP0490181A1 (enExample)
JP (1) JPH06100450A (enExample)
KR (1) KR920009399A (enExample)
CA (1) CA2056723A1 (enExample)
HU (1) HUT59825A (enExample)
IE (1) IE914163A1 (enExample)
IL (1) IL100195A0 (enExample)
PT (1) PT99659A (enExample)
TW (1) TW205507B (enExample)
ZA (1) ZA919438B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1214938A3 (en) * 1991-05-24 2003-08-06 Fred Hutchinson Cancer Research Center Modulation of cellular response to external stimuli
DE4411660A1 (de) * 1994-04-05 1995-10-12 Hoechst Ag Verwendung von Xanthinderivaten zur Reduktion der pathologischen Hyperreagibilität eosinophiler Granulozyten, neue Xanthinverbindungen und Verfahren zu deren Herstellung
DE4430127A1 (de) 1994-08-25 1996-03-14 Hoechst Ag Kombinationspräparat, enthaltend Cyclosporin A oder FK506 und ein Xanthinderivat
DE4430128A1 (de) 1994-08-25 1996-02-29 Hoechst Ag Kombinationspräparat mit immunsuppressiven, kardiovaskulären und cerebralen Wirkungen
US6323201B1 (en) 1994-12-29 2001-11-27 The Regents Of The University Of California Compounds for inhibition of ceramide-mediated signal transduction
ATE234099T1 (de) * 1998-04-24 2003-03-15 Leuven K U Res & Dev Immununterdrückende effekte von 8 substituierten xanthinderivaten
US6930101B1 (en) 1999-05-17 2005-08-16 The Regents Of The University Of California Thiazolopyrimidines useful as TNFα inhibitors
US7253176B1 (en) 2000-05-04 2007-08-07 K.U. Leuven Research & Development Immunosuppressive effects of 8-substituted xanthine derivatives
WO2009108383A2 (en) 2008-02-29 2009-09-03 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
US20110053961A1 (en) 2009-02-27 2011-03-03 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
WO2011028835A1 (en) 2009-09-02 2011-03-10 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
EP2611807A2 (en) 2010-09-01 2013-07-10 Concert Pharmaceuticals Inc. Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3-7-dimethyl-1h-purine-2,6(3h,7h)dione
WO2013013052A1 (en) 2011-07-19 2013-01-24 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
MX2014012384A (es) 2012-04-13 2014-11-26 Concert Pharmaceuticals Inc Derivados sustituidos de xantina.
WO2013159006A1 (en) 2012-04-20 2013-10-24 Concert Pharmaceuticals, Inc. Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3,7-dimethyl-1h-purine-2,6(3h,7h)-dione
US9549869B2 (en) 2012-06-29 2017-01-24 Hill-Rom Canado Respiratory Ltd. Wearable thorax percussion device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0063827B1 (fr) * 1980-05-02 1985-08-14 Societe Des Produits Nestle S.A. 1-Isopropyl- et 1-isobutyl-3,7-diméthylxanthine comme médicaments
IL100536A (en) * 1986-12-31 1994-05-30 Hoechst Roussel Pharma Pharmaceutical preparations containing a history of xanthine Stopping an immune response and relieving adverse conditions resulting from intracellular intervention in an immune response
US4965271A (en) * 1986-12-31 1990-10-23 Hoechst Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
GB8918297D0 (en) * 1989-08-10 1989-09-20 Beecham Group Plc Novel treatment

Also Published As

Publication number Publication date
ZA919438B (en) 1992-08-26
EP0490181A1 (en) 1992-06-17
IE914163A1 (en) 1992-06-03
HUT59825A (en) 1992-07-28
HU913721D0 (en) 1992-02-28
PT99659A (pt) 1992-10-30
IL100195A0 (en) 1992-08-18
CA2056723A1 (en) 1992-05-31
KR920009399A (ko) 1992-06-25
JPH06100450A (ja) 1994-04-12

Similar Documents

Publication Publication Date Title
TW205507B (enExample)
TW202444B (enExample)
CA2112239C (en) Enantiomeric hydroxylated xanthine compounds
US20250059169A1 (en) Pyrazole-1(2h)-phthalazinone compound and application thereof
US5981535A (en) Substituted xanthines and their use in the treatment of cerebrovascular disorders and other diseases
US12371431B2 (en) Trifluoromethyl-substituted sulfonamide as BCL-2-selective inhibitor
CN105358560A (zh) 双重选择性PI3δ和γ激酶抑制剂
TW213445B (enExample)
JPH02501829A (ja) インターロイキン‐１の活性を抑制する方法
JPH07500108A (ja) 抗アレルギー、抗炎症および腫瘍壊死因子抑制活性を有するシクロペンタンおよびシクロペンテン誘導体
JPH08175990A (ja) Ｐｉ３キナーゼ阻害剤とその製造法
GB2159712A (en) Containing a polyprenyl compound
US20230113620A1 (en) Use of jak inhibitors in preparation of drugs for treating jak kinase-related diseases
TW209169B (enExample)
US20230158150A1 (en) Compound comprising a nucleic acid and a half-life extension motif
US6420374B1 (en) Use of xanthines as immunosuppressants and to inhibit allograft reactions
CA2373410C (en) A2a receptor agonists
JP2024526243A (ja) ジメチル置換チアゾロラクタム化合物及びその使用
CN114262326A (zh) 小分子化合物wj644a及其在制备治疗前列腺癌疾病的药物中的应用
JPH0667880B2 (ja) ｇｅｍ−ジハロ−１，８−ジアミノ−４−アザ−オクタン類
CN115551842B (zh) 联苯类化合物
CN113461528B (zh) 一种苯氧酸类衍生物及其应用
AU628400B2 (en) Prostaglandin-derivatives having antithrombotic activity
TWI410419B (zh) 嘧啶基吲哚化合物
HK40110510A (en) Compound containing cycloalkyl or haloalkyl